Biallelic pathogenic variants of PARS2 cause developmental and epileptic encephalopathy with spike-and-wave activation in sleep

被引:2
|
作者
Licchetta, Laura [1 ,4 ]
Di Giorgi, Lucia [1 ,2 ]
Santucci, Margherita [3 ]
Taruffi, Lisa [1 ]
Stipa, Carlotta [1 ]
Minardi, Raffaella [1 ]
Carelli, Valerio [1 ,3 ]
Bisulli, Francesca [1 ,3 ]
机构
[1] IRCCS Ist Sci Neurol Bologna, European Reference Network EpiCARE Bologna, Bologna, Italy
[2] Univ Palermo, Dept Biomed Neurosci & Adv Diagnost, Palermo, Italy
[3] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy
[4] Bellaria Hosp, IRCCS Ist Sci Neurol Bologna, European Reference Network EpiCARE Bologna, Via Altura 3, I-40139 Bologna, Italy
来源
MOLECULAR GENETICS & GENOMIC MEDICINE | 2024年 / 12卷 / 01期
关键词
continuous spikes and waves during slow sleep (CSWS); developmental and epileptic encephalopathy (DEE); PARS2; spike-and-wave activation in sleep (SWAS); MUTATIONS; NARS2;
D O I
10.1002/mgg3.2311
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
BackgroundBiallelic pathogenic variants in the mitochondrial prolyl-tRNA synthetase 2 gene (PARS2, OMIM * 612036) have been associated with Developmental and Epileptic Encephalopathy-75 (DEE-75, MIM #618437). This condition is typically characterized by early-onset refractory infantile spasms with hypsarrhythmia, intellectual disability, microcephaly, cerebral atrophy with hypomyelination, lactic acidemia, and cardiomyopathy. Most affected individuals do not survive beyond the age of 10 years.MethodsWe describe a patient with early-onset DEE, consistently showing an EEG pattern of Spike-and-Wave Activation in Sleep (SWAS) since childhood. The patient underwent extensive clinical, metabolic and genetic investigations, including whole exome sequencing (WES).ResultsWES analysis identified compound heterozygous variants in PARS2 that have been already reported as pathogenic. A literature review of PARS2-associated DEE, focusing mainly on the electroclinical phenotype, did not reveal the association of SWAS with pathogenic variants in PARS2. Notably, unlike previously reported cases with the same genotype, this patient had longer survival without cardiac involvement or lactic acidosis, suggesting potential genetic modifiers contributing to disease variability.ResultsWES analysis identified compound heterozygous variants in PARS2 that have been already reported as pathogenic. A literature review of PARS2-associated DEE, focusing mainly on the electroclinical phenotype, did not reveal the association of SWAS with pathogenic variants in PARS2. Notably, unlike previously reported cases with the same genotype, this patient had longer survival without cardiac involvement or lactic acidosis, suggesting potential genetic modifiers contributing to disease variability.ConclusionThese findings widen the genetic heterogeneity of DEE-SWAS, including PARS2 as a causative gene in this syndromic entity, and highlight the importance of prolonged sleep EEG recording for the recognition of SWAS as a possible electroclinical evolution of PARS2-related DEE.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Coexistence of epileptic encephalopathy with continuous spike-and-wave during sleep, atypical benign partial epilepsy, and fixation-off sensitivity in two siblings
    Saadeldin, Imad Yassin
    Al-Tala, Saeed M.
    EPILEPSY & BEHAVIOR, 2011, 20 (01) : 116 - 122
  • [42] Diagnostic and prognostic significance of serum interleukins in epileptic encephalopathy with spike wave activation in sleep (EE-SWAS) syndrome
    Jauhari, Prashant
    Kaur, Prabhjot
    Gulati, Sheffali
    Meena, Ankit Kumar
    Pandey, Tapish
    Upadhyay, Ashish
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2024, 53 : 33 - 38
  • [43] Acetazolamide for developmental and/or epileptic encephalopathy with spike-wave activation in sleep (D/EE-SWAS). Experience Dr Exequiel Gonzalez Cortes Hospital, Chile
    Lopez, M. F.
    Julio, K.
    Nunez, P.
    Quintana, C.
    Gaete, R.
    Gonzalez, J.
    EPILEPSIA, 2023, 64 : 561 - 562
  • [44] Developmental and/or Epileptic Encephalopathy with spike-wave activation in sleep (D/EE-SWAS) - Aetiology, clinical characteristics, and treatment response in a cohort of 50 children
    Kravljanac, R.
    Tadic, B. Vucetic
    Ostojic, S.
    Savkic, J.
    Nikolic, L.
    EPILEPSIA, 2024, 65 : 398 - 398
  • [45] Missense Variants in RHOBTB2 Cause a Developmental and Epileptic Encephalopathy in Humans, and Altered Levels Cause Neurological Defects in Drosophila
    Straub, Jonas
    Konrad, Enrico D. H.
    Gruener, Johanna
    Toutain, Annick
    Bok, Levinus A.
    Cho, Megan T.
    Crawford, Heather P.
    Dubbs, Holly
    Douglas, Ganka
    Jobling, Rebekah
    Johnson, Diana
    Krock, Bryan
    Mikati, Mohamad A.
    Nesbitt, Addie
    Nicolai, Joost
    Phillips, Meredith
    Poduri, Annapurna
    Ortiz-Gonzalez, Xilma R.
    Powis, Zoe
    Santani, Avni
    Smith, Lacey
    Stegmann, Alexander P. A.
    Stumpel, Constance
    Vreeburg, Maaike
    Fliedner, Anna
    Gregor, Anne
    Sticht, Heinrich
    Zweier, Christiane
    AMERICAN JOURNAL OF HUMAN GENETICS, 2018, 102 (01) : 44 - 57
  • [46] De novo variants in CELF2 that disrupt the nuclear localization signal cause developmental and epileptic encephalopathy
    Itai, Toshiyuki
    Hamanaka, Kohei
    Sasaki, Kazunori
    Wagner, Matias
    Kotzaeridou, Urania
    Brosse, Ines
    Ries, Markus
    Kobayashi, Yu
    Tohyama, Jun
    Kato, Mitsuhiro
    Ong, Winnie P.
    Chew, Hui B.
    Rethanavelu, Kavitha
    Ranza, Emmanuelle
    Blanc, Xavier
    Uchiyama, Yuri
    Tsuchida, Naomi
    Fujita, Atsushi
    Azuma, Yoshiteru
    Koshimizu, Eriko
    Mizuguchi, Takeshi
    Takata, Atsushi
    Miyake, Noriko
    Takahashi, Hidehisa
    Miyagi, Etsuko
    Tsurusaki, Yoshinori
    Doi, Hiroshi
    Taguri, Masataka
    Antonarakis, Stylianos E.
    Nakashima, Mitsuko
    Saitsu, Hirotomo
    Miyatake, Satoko
    Matsumoto, Naomichi
    HUMAN MUTATION, 2021, 42 (01) : 66 - 76
  • [47] De novo gain-of-function variants in KCNT2 as a novel cause of developmental and epileptic encephalopathy
    Ambrosino, Paolo
    Soldovieri, Maria Virginia
    Bast, Thomas
    Turnpenny, Peter D.
    Uhrig, Sabine
    Biskup, Saskia
    Doecker, Miriam
    Fleck, Thilo
    Mosca, Ilaria
    Manocchio, Laura
    Iraci, Nunzio
    Taglialatela, Maurizio
    Lemke, Johannes R.
    ANNALS OF NEUROLOGY, 2018, 83 (06) : 1198 - 1204
  • [48] Etiological and clinical spectrum of developmental and/or epileptic encephalopathy with spike-wave activation in sleep (D/EE-SWAS) - tertiary center experience in a cohort of 43 children
    Kravljanac, R.
    Vucetic-Tadic, B.
    Nikolic, L.
    Savkic, J.
    EPILEPSIA, 2023, 64 : 440 - 440
  • [49] De novo pathogenic variants in neuronal differentiation factor 2 (NEUROD2) cause a form of early infantile epileptic encephalopathy
    Sega, Annalisa G.
    Mis, Emily K.
    Lindstrom, Kristin
    Mercimek-Andrews, Saadet
    Ji, Weizhen
    Cho, Megan T.
    Juusola, Jane
    Konstantino, Monica
    Jeffries, Lauren
    Khokha, Mustafa K.
    Lakhani, Saquib Ali
    JOURNAL OF MEDICAL GENETICS, 2019, 56 (02) : 113 - 122
  • [50] De novo missense variants in RHOBTB2 cause a developmental and epileptic encephalopathy in humans, and altered levels cause neurological defects in Drosophila
    Straub, J.
    Konrad, E. D. H.
    Gruener, J.
    Toutain, A.
    Bok, L. A.
    Cho, M. T.
    Crawford, H. P.
    Dubbs, H.
    Douglas, G.
    Jobling, R.
    Johnson, D.
    Krock, B.
    Mikati, M. A.
    Nesbitt, A.
    Nicolai, J.
    Phillips, M.
    Poduri, A.
    Ortiz-Gonzales, X. R.
    Powis, Z.
    Santani, A.
    Smith, L.
    Stegmann, A. P. A.
    Stumpel, C.
    Vreeburg, M.
    Study, D. D. D.
    Fliedner, A.
    Gregor, A.
    Sticht, H.
    Zweier, C.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 850 - 851